Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the immune system to transform the treatment of solid tumors and genetic diseases. Our approach is to rationally combine immune modulating small molecules (VEPOs?) with gene delivery and biological therapeutic elements. We create efficacious therapeutic products to address unmet patient needs.